The Increased Demand For Gvhd Management Is Expected To Aid In The Growth Of The Global Graft Versus Host Disease Market
Graft-versus-host disease (GvHD) is a rare condition that occurs after transplant surgeries in which the donor's immune cells attack the recipient's organ tissues. It happens following a stem cell or bone marrow transplant. To repair damaged cells surrounding cancer tumours, treatments involving stem cells and bone marrow transplants are used. Normally, after a high-dose treatment, the patient receives bone marrow from a donor via a drip, resuming blood cell production. When specific types of white blood cells infect the host, the risk of developing GvHD skyrockets. This is due to the transplanted cells (graft) perceiving the recipient's body (host) as exotic, causing the transplanted cells to attack the host body. It is impossible to predict who will develop GvHD after a transplant. A mild form of GvHD is seen in a few cases. While GvHD can be fatal in some circumstances. Increased r&d activities are expected to drive the growth of the global Graft Versus Host Dise